PODXL anticorps (C-Term)
Aperçu rapide pour PODXL anticorps (C-Term) (ABIN374787)
Antigène
Voir toutes PODXL AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- C-Term
-
Specificité
- This antibody reacts to PODXL.
-
Réactivité croisée (Details)
-
Species reactivity (expected):Canine.
Species reactivity (tested):Human, Mouse, Rat. -
Purification
- Affinity chromatography
-
Immunogène
- Peptide with sequence C-DNLTKDDLDEEEDTH, from the C Terminus of the protein sequence
-
-
-
-
Indications d'application
-
Peptide ELISA: 1/64000. Western Blot: 0.5 - 1.5 μg/mL.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user. -
Restrictions
- For Research Use only
-
-
-
Concentration
- 0.5 mg/mL
-
Buffer
- Tris saline, 0.02 % sodium azide, pH 7.3 with 0.5 % bovine serum albumin
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Conseil sur la manipulation
- Avoid repeated freezing and thawing.
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
- PODXL (Podocalyxin-Like (PODXL))
-
Autre désignation
- Podocalyxin / PODXL
-
Sujet
- Podocalyxin-like protein (PODXL) is a transmembrane sialomucin that is similar instructure to the well-characterized L-selectin ligand CD34. PCLP has been shown previously to be expressed on the foot processes of podocytes in the kidney glomerulus as well as on vascular endothelium at some sites. PODXL also has a putative role as a diagnostic marker for a number of cancers including pancreatic ductal carcinomas and prostate cancer.Synonyms: GCTM-2 antigen, Hematopoietic Stem Cell Marker, PCLP, PCLP-1, PCLP1, Podocalyxin-like protein 1
-
ID gène
- 5420
-
NCBI Accession
- NP_001018121
-
UniProt
- O00592
-
Pathways
- Tube Formation
Antigène
-